Everence Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.45M | Hold |
70,254
| – | – | 0.52% | 29 |
|
|
2025
Q4 | $7.39M | Sell |
70,254
-6,817
| -9% | -$640K | 0.44% | 33 |
|
|
2025
Q3 | $6.47M | Buy |
77,071
+4,640
| +6% | +$382K | 0.39% | 38 |
|
|
2025
Q2 | $5.73M | Sell |
72,431
-3,340
| -4% | -$265K | 0.37% | 42 |
|
|
2025
Q1 | $6.8M | Buy |
75,771
+4,510
| +6% | +$421K | 0.46% | 36 |
|
|
2024
Q4 | $7.09M | Sell |
71,261
-16,830
| -19% | -$1.74M | 0.46% | 33 |
|
|
2024
Q3 | $10M | Hold |
88,091
| – | – | 0.63% | 28 |
|
|
2024
Q2 | $11.4K | Hold |
88,091
| – | – | 0.79% | 21 |
|
|
2024
Q1 | $11.6K | Hold |
88,091
| – | – | 0.77% | 22 |
|
|
2023
Q4 | $9.6M | Buy |
88,091
+20,700
| +31% | +$2.15M | 0.69% | 24 |
|
|
2023
Q3 | $6.94K | Sell |
67,391
-10,580
| -14% | -$1.14M | 0.54% | 28 |
|
|
2023
Q2 | $8.61M | Hold |
77,971
| – | – | 0.7% | 24 |
|
|
2023
Q1 | $8.29K | Hold |
77,971
| – | – | 0.68% | 24 |
|
|
2022
Q4 | $8.65K | Buy |
77,971
+11,270
| +17% | +$1.15M | 0.75% | 21 |
|
|
2022
Q3 | $5.74M | Hold |
66,701
| – | – | 0.53% | 30 |
|
|
2022
Q2 | $6.08M | Hold |
66,701
| – | – | 0.54% | 30 |
|
|
2022
Q1 | $5.47M | Sell |
66,701
-2,310
| -3% | -$182K | 0.42% | 43 |
|
|
2021
Q4 | $5.29M | Buy |
69,011
+18,530
| +37% | +$1.48M | 0.39% | 45 |
|
|
2021
Q3 | $3.79M | Sell |
50,481
-9,130
| -15% | -$694K | 0.31% | 56 |
|
|
2021
Q2 | $4.64M | Sell |
59,611
-2,861
| -5% | -$213K | 0.38% | 48 |
|
|
2021
Q1 | $4.59M | Hold |
62,472
| – | – | 0.42% | 41 |
|
|
2020
Q4 | $4.88M | Sell |
62,472
-12,052
| -16% | -$922K | 0.48% | 37 |
|
|
2020
Q3 | $5.9M | Hold |
74,524
| – | – | 0.65% | 23 |
|
|
2020
Q2 | $5.74M | Buy |
74,524
+6,927
| +10% | +$521K | 0.68% | 20 |
|
|
2020
Q1 | $4.96M | Hold |
67,597
| – | – | 0.7% | 20 |
|
|
2019
Q4 | $5.87M | Sell |
67,597
-1,698
| -2% | -$139K | 0.88% | 18 |
|
|
2019
Q3 | $5.57M | Hold |
69,295
| – | – | 0.9% | 18 |
|
|
2019
Q2 | $5.54M | Hold |
69,295
| – | – | 0.92% | 15 |
|
|
2019
Q1 | $5.5M | Buy |
69,295
+7,771
| +13% | +$581K | 0.96% | 15 |
|
|
2018
Q4 | $4.49M | Hold |
61,524
| – | – | 1.04% | 13 |
|
|
2018
Q3 | $4.17M | Hold |
61,524
| – | – | 0.83% | 18 |
|
|
2018
Q2 | $3.56M | Hold |
61,524
| – | – | 0.75% | 22 |
|
|
2018
Q1 | $3.2M | Sell |
61,524
-6,571
| -10% | -$355K | 0.71% | 27 |
|
|
2017
Q4 | $3.66M | Buy |
68,095
+787
| +1% | +$43.6K | 0.8% | 24 |
|
|
2017
Q3 | $4.11M | Buy |
67,308
+2,903
| +5% | +$176K | 0.94% | 20 |
|
|
2017
Q2 | $3.94M | Hold |
64,405
| – | – | 0.97% | 18 |
|
|
2017
Q1 | $3.9M | Hold |
64,405
| – | – | 1.03% | 19 |
|
|
2016
Q4 | $3.62M | Sell |
64,405
-1,769
| -3% | -$104K | 1.04% | 19 |
|
|
2016
Q3 | $3.94M | Sell |
66,174
-3,584
| -5% | -$210K | 1.17% | 13 |
|
|
2016
Q2 | $3.83M | Sell |
69,758
-1,949
| -3% | -$104K | 1.18% | 13 |
|
|
2016
Q1 | $3.62M | Hold |
71,707
| – | – | 1.13% | 15 |
|
|
2015
Q4 | $3.61M | Buy |
71,707
+7,983
| +13% | +$402K | 1.17% | 14 |
|
|
2015
Q3 | $3M | Hold |
63,724
| – | – | 1.04% | 19 |
|
|
2015
Q2 | $3.46M | Buy |
63,724
+4,695
| +8% | +$263K | 1.12% | 11 |
|
|
2015
Q1 | $3.3M | Buy |
59,029
+2,641
| +5% | +$150K | 1.11% | 14 |
|
|
2014
Q4 | $3.06M | Hold |
56,388
| – | – | 1.05% | 15 |
|
|
2014
Q3 | $3.23M | Hold |
56,388
| – | – | 1.18% | 12 |
|
|
2014
Q2 | $3.11M | Buy |
56,388
+2,096
| +4% | +$114K | 1.15% | 14 |
|
|
2014
Q1 | $2.94M | Sell |
54,292
-2,840
| -5% | -$147K | 1.16% | 13 |
|
|
2013
Q4 | $2.73M | Sell |
57,132
-12,295
| -18% | -$562K | 1.1% | 16 |
|
|
2013
Q3 | $3.15M | Hold |
69,427
| – | – | 1.35% | 10 |
|
|
2013
Q2 | $3.08M | Buy |
+69,427
| New | +$3.1M | 1.39% | 10 |
|
Other funds holding MRK
VCM
VPM
Everence Capital Management's MRK Position: Q1 2026 in Review
Everence Capital Management held its Merck (MRK) position steady in Q1 2026 at 70,254 shares worth $8.45M. The position accounts for 0.52% of the portfolio, ranked #29.
Everence Capital Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $10M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Everence Capital Management held 70,254 shares of Merck worth $8.45M as of Q1 2026.
- Everence Capital Management left its Merck share count unchanged in Q1 2026.
- Merck made up 0.52% of Everence Capital Management's portfolio in Q1 2026, its #29 holding.
- Everence Capital Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Everence Capital Management's Merck position peaked at $10M in Q3 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.